We use cookies to improve your experience on our site. To find out more, please read our privacy policy and cookie policy.

Virtual healthcare

The latest Editorial from @JanssenEMEA discusses why understanding the molecular biology of #lungcancer https://t.co/KwRJhwVOli

RT @jsoriamd: #ESMO20 KEYNOTE024 1L Pembro vs CT in PDL1+ >50% #lcsm, 5 year OS 31.9% in pembro arm vs 16% in CT arm (despite 66% cross-ove…

#ESMO20 PROfound trial concludes #olaparib should become the new standard treatment for #prostatecancer. Read the f… https://t.co/cYcxRgPQgN

Oncology Central is powered by Future Medicine, part of Future Science Group

Oncology Central, Unitec House, 2 Albert Place, London, N3 1QB, UK